nicotinamide N-methyltransferase inhibitors (Ridgeline Therapeutics)

N/A

Report date: 2025/01/26 16:37:56
NME

Base Information

Drug Namenicotinamide N-methyltransferase inhibitors (Ridgeline Therapeutics)
Drug Alias NameNNMT inhibitor (Ridgeline Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinamide N-methyltransferase inhibitors
TargetsNicotinamide N-methyltransferase
Therapy Area/IndicationsHealthy AgingSarcopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas Medical Branch
China Registration ClassN/A

Develop Information

Active CompaniesRidgeline Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsHealthy AgingSarcopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A